PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS

The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, resp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BARRANCO HERNANDEZ, GUSTAVO, SENOSIAIN ARROYO, HECTOR
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BARRANCO HERNANDEZ, GUSTAVO
SENOSIAIN ARROYO, HECTOR
description The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, respiratory sincitial virus and adenovirus, among others. L'invention concerne une composition comprenant de la curcumine et de l'arginine, destinée à être utilisée dans le traitement de l'infection respiratoire causée par le SARS-CoV-2, par administration nasale.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3241241A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3241241A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3241241A13</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeod5gB20dYLjOnEBppMySRC3ZQicSVaqAfw6FbwAMKHt3iPv87eXYPeoqIYjMIWFNuOxQTDDjR7CA1B8ITBkgvAGozTpBYdBTxJZzwG9j3URgiFBBRGoRqO_bdsI7kLAroaBL3kis95uQe07E7Ay7eXbba6jfc57X7cZKApqCZP03NI8zRe0yO9BoVVeSiWYVH9kXwAJPE7tA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS</title><source>esp@cenet</source><creator>BARRANCO HERNANDEZ, GUSTAVO ; SENOSIAIN ARROYO, HECTOR</creator><creatorcontrib>BARRANCO HERNANDEZ, GUSTAVO ; SENOSIAIN ARROYO, HECTOR</creatorcontrib><description>The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, respiratory sincitial virus and adenovirus, among others. L'invention concerne une composition comprenant de la curcumine et de l'arginine, destinée à être utilisée dans le traitement de l'infection respiratoire causée par le SARS-CoV-2, par administration nasale.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230622&amp;DB=EPODOC&amp;CC=CA&amp;NR=3241241A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230622&amp;DB=EPODOC&amp;CC=CA&amp;NR=3241241A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BARRANCO HERNANDEZ, GUSTAVO</creatorcontrib><creatorcontrib>SENOSIAIN ARROYO, HECTOR</creatorcontrib><title>PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS</title><description>The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, respiratory sincitial virus and adenovirus, among others. L'invention concerne une composition comprenant de la curcumine et de l'arginine, destinée à être utilisée dans le traitement de l'infection respiratoire causée par le SARS-CoV-2, par administration nasale.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeod5gB20dYLjOnEBppMySRC3ZQicSVaqAfw6FbwAMKHt3iPv87eXYPeoqIYjMIWFNuOxQTDDjR7CA1B8ITBkgvAGozTpBYdBTxJZzwG9j3URgiFBBRGoRqO_bdsI7kLAroaBL3kis95uQe07E7Ay7eXbba6jfc57X7cZKApqCZP03NI8zRe0yO9BoVVeSiWYVH9kXwAJPE7tA</recordid><startdate>20230622</startdate><enddate>20230622</enddate><creator>BARRANCO HERNANDEZ, GUSTAVO</creator><creator>SENOSIAIN ARROYO, HECTOR</creator><scope>EVB</scope></search><sort><creationdate>20230622</creationdate><title>PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS</title><author>BARRANCO HERNANDEZ, GUSTAVO ; SENOSIAIN ARROYO, HECTOR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3241241A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BARRANCO HERNANDEZ, GUSTAVO</creatorcontrib><creatorcontrib>SENOSIAIN ARROYO, HECTOR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BARRANCO HERNANDEZ, GUSTAVO</au><au>SENOSIAIN ARROYO, HECTOR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS</title><date>2023-06-22</date><risdate>2023</risdate><abstract>The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, respiratory sincitial virus and adenovirus, among others. L'invention concerne une composition comprenant de la curcumine et de l'arginine, destinée à être utilisée dans le traitement de l'infection respiratoire causée par le SARS-CoV-2, par administration nasale.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3241241A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T22%3A46%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BARRANCO%20HERNANDEZ,%20GUSTAVO&rft.date=2023-06-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3241241A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true